CALL FOR ENTRIES
Interested in competing for the prize?
Click here to submit your prize entry
Note: if you plan on only attending the reception for the Innovation Prize, please register. If you plan on competing for the prize, click above for entry and submission to the contest and make sure to register. Learn more here!
Celebrating the Spirit of Innovation
Our Innovation Prize recognizes the challenge and dedication it takes to start a new company by supporting the innovation process and celebrating life-science entrepreneurs. Boehringer Ingelheim, together with the Boehringer Ingelheim Venture Fund, will award one early-stage bioscience organization the 2019 Boston Innovation Prize on December 19th, 2019.
The Innovation Prize
Valued at $75,000, the winner, who will be announced during a Networking Reception that evening, will receive Boehringer Ingelheim’s ‘Golden Ticket’ – a voucher which represents prepaid rent for one reserved bench in LabCentral’s shared laboratory space in Cambridge, MA. for one year. Boehringer Ingelheim receives this ‘Golden Ticket’ as part of its sponsorship of the LabCentral facility.
Shortlisted applicants will be invited to present their ideas in a poster session at the Cambridge Innovation Center on December 19th, from which a final short-list is selected to pitch their ideas to a panel of judges.
Early-stage innovators and spin-outs that are pursuing life-science therapeutic platform technologies and therapeutics (in any indication, any modality) are invited to participate. Diagnostics, Instrument development, and Health-IT are excluded.
Companies must be founded and have their principle place of business in Massachusetts.
Companies must not have a major partnership with another large bio-pharmaceutical company.
Companies must be focused on new target concepts or drug discovery.
How to Apply
Applicants must provide a non-confidential deck of no more than ten slides. Slides must address unmet medical need, solution, scientific principle, key data supporting the scientific principle, overview of business case, and intellectual property.
ALL APPLICATIONS MUST BE SUBMITTED BY END OF BUSINESS, NOVEMBER 22nd, 2019